Launched in June 2021, the Turing-Roche Strategic Partnership is a five-year collaboration between The Alan Turing Institute and Roche.

The partnership’s ‘North Star’ is to enable the generation of insights to better understand patient and disease heterogeneity and its relevance to clinical outcomes at an unprecedented level of precision in order to improve clinical care. 

Last year the partnership ran a funding call and associated workshops on the theme of structured missingness, funding two 18-month projects. This year they are exploring the theme of predictive modelling in the face of uncertainty and heterogeneity in biomedical data, and inviting applications for funding.

Similar to last year’s successful model, a workshop will be held for researchers to encourage discussion and exploration of this theme and have the opportunity to meet others to develop potential collaborative proposals for the call.

Key Dates

Call opens: 5 September 2022
Call closes: 14 November 2022
(Optional) Information and Q&A session: 19 September 2022
(Optional) Collaborative in-person workshop: 11 October 2022
(Optional) Virtual co-working sessions: 20 and 28 October 2022
Notification of outcome: By 23 December 2022
Award start date: 1 March 2023

Further details and guidance on how to apply via the Alan Turing Institute.